Related Experiment Videos
Bacithrocins A, B and C, novel thrombin inhibitors
T Kamiyama1, T Umino, Y Nakamura
1Nippon Roche Research Center, Kanagawa, Japan.
The Journal of Antibiotics
|September 1, 1994
Summary
Novel thrombin inhibitors, bacithrocins A, B, and C, were discovered from Bacillus laterosporus. These compounds effectively inhibit thrombin and factor Xa, prolonging clotting time.
Area of Science:
- Biochemistry
- Microbiology
- Pharmacology
Background:
- Thrombin and factor Xa are critical enzymes in the blood coagulation cascade.
- Development of novel anticoagulants is essential for managing thrombotic disorders.
Purpose of the Study:
- To isolate and characterize novel thrombin inhibitors from Bacillus laterosporus.
- To evaluate the inhibitory activity and structural features of these novel compounds.
Main Methods:
- Isolation of bacithrocins A, B, and C from Bacillus laterosporus culture broth.
- Structure elucidation using 2D-NMR and amino acid analysis.
- Enzyme inhibition assays to determine IC50 values against thrombin, factor Xa, and trypsin.
Main Results:
- Bacithrocins A, B, and C were identified as N-acyl-L-phenylalanyl-DL-arginal.
- Bacithrocin A demonstrated IC50 values of 48 microM for thrombin, 13 microM for factor Xa, and 0.65 microM for trypsin.
- All bacithrocins prolonged clotting times induced by thrombin and factor Xa.
Conclusions:
- Bacillus laterosporus produces novel peptide inhibitors, bacithrocins A, B, and C.
- These bacithrocins exhibit significant inhibitory activity against thrombin and factor Xa.
- The findings suggest potential therapeutic applications for bacithrocins as anticoagulants.